Related Experiment Video
Updated: Sep 22, 2026

Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells
Published on: June 15, 2013
Insulin-like peptides in the lobster Homarus americanus. I. Insulin immunoreactivity
Experiments were conducted to determine if insulin-like peptides are present in the lobster Homarus americanus. Peptides were found that bind specifically to bovine insulin antibodies in a modified vertebrate radioimmunoassay. Extracts of whole hepatopancreas, gut, and hemolymph contained insulin immunoreactivity (IRI) concentrations of 67.5, 14.0, and 11.0 ng, respectively, per 700-g lobster. No insulin immunoreactivity was detected in neurosecretory cells of the eyestalk. The highest immunoreactivity was measured in the hepatopancreas, in the same fractions of eluate which contained the highest immunoreactivity when a bovine insulin standard was passed through the same chromatographic column.
Experiments were conducted to determine if insulin-like peptides are present in the lobster Homarus americanus. Peptides were found that bind specifically to bovine insulin antibodies in a modified vertebrate radioimmunoassay. Extracts of whole hepatopancreas, gut, and hemolymph contained insulin immunoreactivity (IRI) concentrations of 67.5, 14.0, and 11.0 ng, respectively, per 700-g lobster. No insulin immunoreactivity was detected in neurosecretory cells of the eyestalk. The highest immunoreactivity was measured in the hepatopancreas, in the same fractions of eluate which contained the highest immunoreactivity when a bovine insulin standard was passed through the same chromatographic column.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

